Sage Therapeutics Spicing Up Portfolios
Seeking Alpha,
Summary Lead candidate Brexanolone in phase 2/3 studies for postpartum depression and epilepsy with encouraging data.
Refractory status epilepticus
Overview of attention for article published in Annals of Indian Academy of Neurology, January 2014
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (89th percentile)
-
High Attention Score compared to outputs of the same age and source (86th percentile)
Readers on
- mendeley
- 65 Mendeley